R
Richard T. Ramsden
Researcher at Manchester Royal Infirmary
Publications - 162
Citations - 5581
Richard T. Ramsden is an academic researcher from Manchester Royal Infirmary. The author has contributed to research in topics: Cochlear implant & Neurofibromatosis. The author has an hindex of 36, co-authored 162 publications receiving 5257 citations. Previous affiliations of Richard T. Ramsden include University Hospitals Bristol NHS Foundation Trust & Central Manchester University Hospitals NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.
D. G. R. Evans,Susan M Huson,Dian Donnai,W. Neary,V. Blair,D Teare,Valerie Newton,Tom Strachan,Richard T. Ramsden,Ron Harris +9 more
TL;DR: In this article, a clinical and genetic study of type 2 neurofibromatosis (NF2) has been carried out in the United Kingdom and the results show that there are two types of NF2, one with later onset and bilateral vestibular schwannomas as the only usual feature and the other with earlier onset and multiple other tumours.
Journal ArticleDOI
Preservation of residual hearing with cochlear implantation: how and why.
Christopher J. James,Klaus Albegger,Rolf D. Battmer,Sandro Burdo,Naima Deggouj,Olivier Deguine,Norbert Dillier,Michel Gersdorff,Roland Laszig,Thomas Lenarz,Manuel Manrique Rodriguez,Michel Mondain,Erwin Offeciers,Angel Ramos Macías,Richard T. Ramsden,Olivier Sterkers,Ernst Von Wallenberg,B. P. Weber,Bernard Fraysse +18 more
TL;DR: Hearing may be conserved in adults after implantation with the Nucleus Contour Advance perimodiolar electrode array and the benefits of combined electrical and acoustic stimulation are presented.
Journal ArticleDOI
Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes
TL;DR: It is indicated that much more caution is warranted regarding the use of radiation treatment for benign tumours in childhood and in tumour prone conditions such as the neurofibromatoses.
Journal ArticleDOI
Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
D. G. R. Evans,Michael E. Baser,B O'Reilly,Jeremy Rowe,Michael Gleeson,Shakeel R. Saeed,Andrew T. King,S. M. Huson,Richard S. C. Kerr,N Thomas,Richard M. Irving,Robert Macfarlane,Rosalie E. Ferner,R McLeod,David A. Moffat,Richard T. Ramsden +15 more
TL;DR: Minimal interference, maintenance of quality of life, and conservation of function or auditory rehabilitation are the cornerstones of NF2 management, and the decision points to achieve these goals for patients with different clinical presentations are discussed.
Journal ArticleDOI
Evaluation of clinical diagnostic criteria for neurofibromatosis 2
TL;DR: None of the existing sets of criteria for neurofibromatosis 2 are adequate at initial assessment for diagnosing people who present without bilateral vestibular schwannomas as having NF2, particularly people with a negative family history of NF2.